Non-contrast Enhanced Cardiac Magnetic Resonance Imaging in the Diagnosis and Classification of Pulmonary Hypertension (CMR-PH)
Sponsor: Medical University of Graz
A NA clinical study on Elevated Mean Pulmonary Arterial Pressure and Normal Mean Pulmonary Arterial Pressure, this trial is ongoing. The trial is conducted by Medical University of Graz and has accumulated 11 data snapshots since 2012. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
11 versions recorded-
Mar 2025 — Present [monthly]
Enrolling By Invitation NA
-
Sep 2024 — Mar 2025 [monthly]
Enrolling By Invitation NA
-
Jul 2024 — Sep 2024 [monthly]
Enrolling By Invitation NA
-
Dec 2023 — Jul 2024 [monthly]
Enrolling By Invitation NA
-
Apr 2023 — Dec 2023 [monthly]
Enrolling By Invitation NA
▶ Show 6 earlier versions
-
Jun 2022 — Apr 2023 [monthly]
Enrolling By Invitation NA
-
Jan 2021 — Jun 2022 [monthly]
Enrolling By Invitation NA
-
Jul 2020 — Jan 2021 [monthly]
Enrolling By Invitation NA
-
Sep 2019 — Jul 2020 [monthly]
Enrolling By Invitation NA
-
Jun 2018 — Sep 2019 [monthly]
Enrolling By Invitation NA
-
Jan 2017 — Jun 2018 [monthly]
Enrolling By Invitation NA
First recorded
Dec 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Medical University of Graz
For direct contact, visit the study record on ClinicalTrials.gov .